Table 1 Patient characteristics.
From: Changes in the gut microbiota after hepatitis C virus eradication
n = 14 | |
|---|---|
Sex (male/female) | 2/12 |
Age (years) | 67.0 (57.3–75.8) |
BMI (kg/m2) | 22.0 (19.9–24.6) |
Glucose (mg/dL) | 94.5 (89.8–112.3) |
Total cholesterol (mg/dL) | 157.5 (138.3–188.3) |
Albumin (g/dL) | 4.2 (3.7–4.4) |
Total bilirubin (mg/dL) | 0.6 (0.6–0.9) |
AST (IU/L) | 26.5 (23.8–48.8) |
ALT (IU/L) | 22.5 (15.8–49.3) |
γ-glutamyl transpeptidase (IU/L) | 18.0 (13.0–31.8) |
Platelet count (× 104/mm3) | 17.2 (13.5–22.2) |
Prothrombin time (%) | 97.2 (79.7–105.9) |
Genotype (1b/1/2b) | 11/2/1 |
HCVRNA (Log IU/mL) | 6.3 (5.3–6.8) |
FIB-4 index | 2.6 (1.1–4.1) |
PPI (present/absent) | 1/13 |
DM (present/absent) | 2/12 |
DAA treatment regimens (EBR/GZR)/(OBV/PTV/r)/(SOF/LDV)/GLE/PIB | 9/2/2/1 |
Treatment duration (8 W/12 W) | 1/13 |
